BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deorukhkar A, Krishnan S. Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol. 2010;80:1904-1914. [PMID: 20599771 DOI: 10.1016/j.bcp.2010.06.039] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Wiesmann N, Gieringer R, Grus F, Brieger J. Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells. Transl Oncol 2019;12:308-19. [PMID: 30453269 DOI: 10.1016/j.tranon.2018.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Liu SC, Tsang NM, Chiang WC, Chang KP, Hsueh C, Liang Y, Juang JL, Chow KP, Chang YS. Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest 2013;123:5269-83. [PMID: 24270418 DOI: 10.1172/JCI63428] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 10.5] [Reference Citation Analysis]
3 Konings K, Vandevoorde C, Baselet B, Baatout S, Moreels M. Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance. Front Oncol 2020;10:128. [PMID: 32117774 DOI: 10.3389/fonc.2020.00128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
4 Durante M, Reppingen N, Held KD. Immunologically augmented cancer treatment using modern radiotherapy. Trends in Molecular Medicine 2013;19:565-82. [DOI: 10.1016/j.molmed.2013.05.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 8.3] [Reference Citation Analysis]
5 Feril LB Jr, Tachibana K. Use of ultrasound in drug delivery systems: emphasis on experimental methodology and mechanisms. Int J Hyperthermia 2012;28:282-9. [PMID: 22621730 DOI: 10.3109/02656736.2012.668640] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
6 Galeaz C, Totis C, Bisio A. Radiation Resistance: A Matter of Transcription Factors. Front Oncol 2021;11:662840. [PMID: 34141616 DOI: 10.3389/fonc.2021.662840] [Reference Citation Analysis]
7 Chen Z, Huang C, Yang YL, Ding Y, Ou-Yang HQ, Zhang YY, Xu M. Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells. Acta Pharmacol Sin 2012;33:101-8. [PMID: 22212432 DOI: 10.1038/aps.2011.164] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
8 Dikshit B, Irshad K, Madan E, Aggarwal N, Sarkar C, Chandra PS, Gupta DK, Chattopadhyay P, Sinha S, Chosdol K. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells. Oncogene 2013;32:3798-808. [DOI: 10.1038/onc.2012.393] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
9 Ullrich M, Richter S, Seifert V, Hauser S, Calsina B, Martínez-Montes ÁM, Ter Laak M, Ziegler CG, Timmers H, Eisenhofer G, Robledo M, Pietzsch J. Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background. Cancers (Basel) 2019;11:E743. [PMID: 31142060 DOI: 10.3390/cancers11060743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fang Z, Li Y, Chen Z, Wang J, Zhu L. Inhibition of Signal Transducer and Activator of Transcription 3 and Cyclooxygenase-2 Is Involved in Radiosensitization of Cepharanthine in HeLa Cells: . International Journal of Gynecological Cancer 2013;23:608-14. [DOI: 10.1097/igc.0b013e31828a05fd] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
12 Martin LM, Marples B, Lynch TH, Hollywood D, Marignol L. Exposure to low dose ionising radiation: Molecular and clinical consequences. Cancer Letters 2014;349:98-106. [DOI: 10.1016/j.canlet.2013.12.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
13 Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol 2016;37:11553-72. [DOI: 10.1007/s13277-016-5098-7] [Cited by in Crossref: 338] [Cited by in F6Publishing: 273] [Article Influence: 67.6] [Reference Citation Analysis]
14 Fu S, Xie Y, Tuo J, Wang Y, Zhu W, Wu S, Yan G, Hu H. Discovery of mitochondria-targeting berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells. Med Chem Commun 2015;6:164-73. [DOI: 10.1039/c4md00264d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP. Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience. 2016;10:610. [PMID: 26823679 DOI: 10.3332/ecancer.2016.610] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
16 Timke C, Winnenthal HS, Klug F, Roeder FF, Bonertz A, Reissfelder C, Rochet N, Koch M, Tjaden C, Buechler MW, Debus J, Werner J, Beckhove P, Weitz J, Huber PE. Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. BMC Cancer 2011;11:134. [PMID: 21489291 DOI: 10.1186/1471-2407-11-134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
17 Yin Z, Li C, Wang J, Xue L. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy: Myeloid-derived suppressor cell. Int J Cancer 2019;144:933-46. [DOI: 10.1002/ijc.31744] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
18 Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One 2017;12:e0180396. [PMID: 28678827 DOI: 10.1371/journal.pone.0180396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
19 Wei D, Morgan MA, Sun Y. Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases. Transl Oncol 2012;5:305-12. [PMID: 23066438 DOI: 10.1593/tlo.12229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
20 Halvorsen AR, Helland A, Fleischer T, Haug KM, Grenaker Alnaes GI, Nebdal D, Syljuåsen RG, Touleimat N, Busato F, Tost J, Saetersdal AB, Børresen-Dale AL, Kristensen V, Edvardsen H. Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy. Int J Cancer 2014;135:2085-95. [PMID: 24658971 DOI: 10.1002/ijc.28862] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
21 Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC, Bravatà V. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm (Lond) 2015;12:14. [PMID: 25705130 DOI: 10.1186/s12950-015-0058-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 22.3] [Reference Citation Analysis]
22 Chang R, He H, Mao G, Kong Z. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells. Int J Radiat Biol 2017;93:386-93. [PMID: 27834104 DOI: 10.1080/09553002.2016.1257831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Wu CT, Chen MF, Chen WC, Hsieh CC. The role of IL-6 in the radiation response of prostate cancer. Radiat Oncol. 2013;8:159. [PMID: 23806095 DOI: 10.1186/1748-717x-8-159] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
24 Zhu Y, Zhang M, Luo L, Gill MR, De Pace C, Battaglia G, Zhang Q, Zhou H, Wu J, Tian Y, Tian X. NF-κB hijacking theranostic Pt(ll) complex in cancer therapy. Theranostics 2019;9:2158-66. [PMID: 31149035 DOI: 10.7150/thno.30886] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
25 Singh J, Sohal SS, Ahuja K, Lim A, Duncan H, Thachil T, De Ieso P. Investigation of circulatory cytokines in patients undergoing intensity-modulated radiotherapy (IMRT) for adenocarcinoma of the prostate and association with acute RT-induced toxicity: A prospective clinical study. Cytokine 2020;131:155108. [PMID: 32330791 DOI: 10.1016/j.cyto.2020.155108] [Reference Citation Analysis]
26 Patwardhan RS, Checker R, Sharma D, Sandur SK, Sainis KB. Involvement of ERK-Nrf-2 signaling in ionizing radiation induced cell death in normal and tumor cells. PLoS One 2013;8:e65929. [PMID: 23776571 DOI: 10.1371/journal.pone.0065929] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
27 Cho E, Park IJ, Yeom SS, Hong SM, Lee JB, Kim YW, Kim MJ, Lim HM, Lim SB, Yu CS, Kim JC. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer. Int J Radiat Oncol Biol Phys 2019;105:834-42. [PMID: 31419511 DOI: 10.1016/j.ijrobp.2019.07.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Hasegawa K, Saga R, Takahashi R, Fukui R, Chiba M, Okumura K, Tsuruga E, Hosokawa Y. 4-methylumbelliferone inhibits clonogenic potency by suppressing high molecular weight-hyaluronan in fibrosarcoma cells. Oncol Lett 2020;19:2801-8. [PMID: 32218833 DOI: 10.3892/ol.2020.11370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Said RS, Mantawy EM, El-Demerdash E. Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects. Naunyn Schmiedebergs Arch Pharmacol 2019;392:1225-38. [PMID: 31129703 DOI: 10.1007/s00210-019-01662-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
30 Multhoff G, Radons J. Radiation, inflammation, and immune responses in cancer. Front Oncol. 2012;2:58. [PMID: 22675673 DOI: 10.3389/fonc.2012.00058] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 9.6] [Reference Citation Analysis]
31 Zhao L, Bode AM, Cao Y, Dong Z. Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis 2012;33:2220-7. [PMID: 22798379 DOI: 10.1093/carcin/bgs235] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 7.8] [Reference Citation Analysis]
32 Matsuoka Y, Nakayama H, Yoshida R, Hirosue A, Nagata M, Tanaka T, Kawahara K, Sakata J, Arita H, Nakashima H, Shinriki S, Fukuma D, Ogi H, Hiraki A, Shinohara M, Toya R, Murakami R. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma. Br J Cancer 2016;115:1234-44. [PMID: 27736845 DOI: 10.1038/bjc.2016.327] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
33 Mowla SN, Perkins ND, Jat PS. Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence. Onco Targets Ther 2013;6:1221-9. [PMID: 24043947 DOI: 10.2147/OTT.S36160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
34 Ma X, Wang R, Yu S, Lu G, Yu Y, Jiang C. Anti-Inflammatory Activity of Oligomeric Proanthocyanidins Via Inhibition of NF-κB and MAPK in LPS-Stimulated MAC-T Cells. J Microbiol Biotechnol 2020;30:1458-66. [PMID: 32876071 DOI: 10.4014/jmb.2006.06030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 de Urbina JJO, San-Miguel B, Vidal-Casariego A, Crespo I, Sánchez DI, Mauriz JL, Culebras JM, González-Gallego J, Tuñón MJ. Effects Of Oral Glutamine on Inflammatory and Autophagy Responses in Cancer Patients Treated With Abdominal Radiotherapy: A Pilot Randomized Trial. Int J Med Sci 2017;14:1065-71. [PMID: 29104459 DOI: 10.7150/ijms.20245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Khoram NM, Bigdeli B, Nikoofar A, Goliaei B. Caffeic Acid Phenethyl Ester Increases Radiosensitivity of Estrogen Receptor-Positive and -Negative Breast Cancer Cells by Prolonging Radiation-Induced DNA Damage. J Breast Cancer 2016;19:18-25. [PMID: 27066092 DOI: 10.4048/jbc.2016.19.1.18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
37 Wang W, Lang J. Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue. Exp Ther Med 2012;4:175-80. [PMID: 22970024 DOI: 10.3892/etm.2012.593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
38 Centurione L, Aiello FB. DNA Repair and Cytokines: TGF-β, IL-6, and Thrombopoietin as Different Biomarkers of Radioresistance. Front Oncol 2016;6:175. [PMID: 27500125 DOI: 10.3389/fonc.2016.00175] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
39 Dos Santos CCM, Uggioni MLR, Colonetti T, Colonetti L, Grande AJ, Da Rosa MI. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review. J Sex Med 2021;18:156-66. [PMID: 33293236 DOI: 10.1016/j.jsxm.2020.10.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Saga R, Matsuya Y, Takahashi R, Hasegawa K, Date H, Hosokawa Y. 4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication. Sci Rep 2021;11:8258. [PMID: 33859324 DOI: 10.1038/s41598-021-87850-3] [Reference Citation Analysis]
41 Hernández-bedolla MA, Carretero-ortega J, Valadez-sánchez M, Vázquez-prado J, Reyes-cruz G. Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2015;1853:166-82. [DOI: 10.1016/j.bbamcr.2014.10.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
42 Begalli F, Bennett J, Capece D, Verzella D, D'Andrea D, Tornatore L, Franzoso G. Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity. Biomedicines 2017;5:E50. [PMID: 28829404 DOI: 10.3390/biomedicines5030050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
43 Berwouts D, De Wolf K, Lambert B, Bultijnck R, De Neve W, De Lobel L, Jans L, Goetghebeur E, Speleers B, Olteanu LA, Madani I, Goethals I, Ost P. Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial. Radiotherapy and Oncology 2015;115:272-8. [DOI: 10.1016/j.radonc.2015.04.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
44 Poltz R, Naumann M. Dynamics of p53 and NF-κB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention. BMC Syst Biol 2012;6:125. [PMID: 22979979 DOI: 10.1186/1752-0509-6-125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
45 Huang T, Yin L, Wu J, Gu JJ, Wu JZ, Chen D, Yu HL, Ding K, Zhang N, Du MY, Qian LX, Lu ZW, He X. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis. J Exp Clin Cancer Res 2016;35:188. [PMID: 27919278 DOI: 10.1186/s13046-016-0465-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
46 Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å. Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy. Adv Radiat Oncol 2018;3:130-8. [PMID: 29904737 DOI: 10.1016/j.adro.2017.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Laine A, Iyengar P, Pandita TK. The role of inflammatory pathways in cancer-associated cachexia and radiation resistance. Mol Cancer Res 2013;11:967-72. [PMID: 23788634 DOI: 10.1158/1541-7786.MCR-13-0189] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
48 Martin LM, Marples B, Lynch TH, Hollywood D, Marignol L. Exposure to low dose ionising radiation: molecular and clinical consequences. Cancer Lett 2013;338:209-18. [PMID: 23693079 DOI: 10.1016/j.canlet.2013.05.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
49 Cirincione R, Di Maggio FM, Forte GI, Minafra L, Bravatà V, Castiglia L, Cavalieri V, Borasi G, Russo G, Lio D. High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities. Ultrasound Med Biol. 2017;43:398-411. [PMID: 27780661 DOI: 10.1016/j.ultrasmedbio.2016.09.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
50 Bochet L, Meulle A, Imbert S, Salles B, Valet P, Muller C. Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun. 2011;411:102-106. [PMID: 21712027 DOI: 10.1016/j.bbrc.2011.06.101] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 8.1] [Reference Citation Analysis]
51 Singh J, Sohal SS, Lim A, Duncan H, Thachil T, De Ieso P. Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings. Ann Transl Med 2019;7:245. [PMID: 31317015 DOI: 10.21037/atm.2019.05.31] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Chung YH, Yu CF, Chiu SC, Chiu H, Hsu ST, Wu CR, Yang CL, Hong JH, Yen TC, Chen FH. Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. Eur J Nucl Med Mol Imaging 2019;46:1733-44. [PMID: 31127350 DOI: 10.1007/s00259-019-04318-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
53 Iwamoto Y, Ishii K, Kanda H, Kato M, Miki M, Kajiwara S, Arima K, Shiraishi T, Sugimura Y. Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells. J Cancer Res Clin Oncol 2017;143:933-9. [PMID: 28243746 DOI: 10.1007/s00432-017-2367-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
54 Huang CY, Tai WT, Wu SY, Shih CT, Chen MH, Tsai MH, Kuo CW, Shiau CW, Hung MH, Chen KF. Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling. Int J Radiat Oncol Biol Phys 2016;95:761-71. [PMID: 26960749 DOI: 10.1016/j.ijrobp.2016.01.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
55 Dzhugashvili M, Luengo-Gil G, García T, González-Conejero R, Conesa-Zamora P, Escolar PP, Calvo F, Vicente V, Ayala de la Peña F. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2014;90:595-602. [PMID: 25304949 DOI: 10.1016/j.ijrobp.2014.06.060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
56 Li J, Volk A, Zhang J, Cannova J, Dai S, Hao C, Hu C, Sun J, Xu Y, Wei W, Breslin P, Nand S, Chen J, Kini A, Zhu J, Zhang J. Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling. Oncotarget 2017;8:8420-35. [PMID: 28039479 DOI: 10.18632/oncotarget.14220] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
57 Allison RR. Radiobiological modifiers in clinical radiation oncology: current reality and future potential. Future Oncol 2014;10:2359-79. [PMID: 25525845 DOI: 10.2217/fon.14.174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Brinkman JA, Liu Y, Kron SJ. Small-molecule drug repurposing to target DNA damage repair and response pathways. Semin Cancer Biol 2021;68:230-41. [PMID: 32113999 DOI: 10.1016/j.semcancer.2020.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
59 De Stefano D, Tommonaro G, Malik SA, Iodice C, De Rosa S, Maiuri MC, Carnuccio R. Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines. PLoS One 2012;7:e33031. [PMID: 22509253 DOI: 10.1371/journal.pone.0033031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
60 Sylvester CB, Abe JI, Patel ZS, Grande-Allen KJ. Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer. Front Cardiovasc Med 2018;5:5. [PMID: 29445728 DOI: 10.3389/fcvm.2018.00005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
61 Jung M, Dimtchev A, Velena A, Dritschilo A. Combining radiation therapy with interstitial radiation-inducible TNF-α expression for locoregional cancer treatment. Cancer Gene Ther 2011;18:189-95. [PMID: 21052099 DOI: 10.1038/cgt.2010.69] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
62 Li XH, Qu JQ, Yi H, Zhang PF, Yi HM, Wan XX, He QY, Ye X, Yuan L, Zhu JF, Li JY, Xiao ZQ. Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells. PLoS One 2014;9:e87767. [PMID: 24498188 DOI: 10.1371/journal.pone.0087767] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
63 Finnberg N, Wambi C, Kennedy AR, El-Deiry WS. The effects of antioxidants on gene expression following gamma-radiation (GR) and proton radiation (PR) in mice in vivo. Cell Cycle 2013;12:2241-7. [PMID: 23797590 DOI: 10.4161/cc.25324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
64 Kleibeuker EA, Griffioen AW, Verheul HM, Slotman BJ, Thijssen VL. Combining angiogenesis inhibition and radiotherapy: A double-edged sword. Drug Resistance Updates 2012;15:173-82. [DOI: 10.1016/j.drup.2012.04.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
65 Huang W, Yu J, Jones JW, Carter CL, Jackson IL, Vujaskovic Z, MacVittie TJ, Kane MA. Acute Proteomic Changes in the Lung After WTLI in a Mouse Model: Identification of Potential Initiating Events for Delayed Effects of Acute Radiation Exposure. Health Phys 2019;116:503-15. [PMID: 30652977 DOI: 10.1097/HP.0000000000000956] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
66 Venkatesulu BP, Mahadevan LS, Aliru ML, Yang X, Bodd MH, Singh PK, Yusuf SW, Abe JI, Krishnan S. Radiation-Induced Endothelial Vascular Injury: A Review of Possible Mechanisms. JACC Basic Transl Sci 2018;3:563-72. [PMID: 30175280 DOI: 10.1016/j.jacbts.2018.01.014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 19.7] [Reference Citation Analysis]
67 Liu R, Zhao D, Zhang X, Han S, Yang Y, Ma J, Meng D. A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation. Oncotarget 2017;8:93103-16. [PMID: 29190981 DOI: 10.18632/oncotarget.21860] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
68 Danhier P, De Saedeleer CJ, Karroum O, De Preter G, Porporato PE, Jordan BF, Gallez B, Sonveaux P. Optimization of Tumor Radiotherapy With Modulators of Cell Metabolism: Toward Clinical Applications. Seminars in Radiation Oncology 2013;23:262-72. [DOI: 10.1016/j.semradonc.2013.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
69 Chen M, Singh AK, Repasky EA. Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance. Cancers (Basel) 2020;12:E3853. [PMID: 33419318 DOI: 10.3390/cancers12123853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Ding M, Zhang E, He R, Wang X. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy. Cancer Sci. 2013;104:1401-1410. [PMID: 23930697 DOI: 10.1111/cas.12252] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
71 Davuluri G, Augoff K, Schiemann WP, Plow EF, Sossey-Alaoui K. WAVE3-NFκB interplay is essential for the survival and invasion of cancer cells. PLoS One 2014;9:e110627. [PMID: 25329315 DOI: 10.1371/journal.pone.0110627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
72 Nguyen AM, Zhou J, Sicairos B, Sonney S, Du Y. Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State. Mol Cell Proteomics 2020;19:375-89. [PMID: 31879272 DOI: 10.1074/mcp.RA119.001779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
73 Bravo-Cuellar A, Hernández-Flores G, Lerma-Díaz JM, Domínguez-Rodríguez JR, Jave-Suárez LF, De Célis-Carrillo R, Aguilar-Lemarroy A, Gómez-Lomeli P, Ortiz-Lazareno PC. Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65. J Biomed Sci 2013;20:13. [PMID: 23445492 DOI: 10.1186/1423-0127-20-13] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
74 Hao F, Kumar S, Yadav N, Chandra D. Neem components as potential agents for cancer prevention and treatment. Biochim Biophys Acta 2014;1846:247-57. [PMID: 25016141 DOI: 10.1016/j.bbcan.2014.07.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
75 Alexeev V, Lash E, Aguillard A, Corsini L, Bitterman A, Ward K, Dicker AP, Linnenbach A, Rodeck U. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound. Mol Cancer Ther 2014;13:2968-77. [PMID: 25398830 DOI: 10.1158/1535-7163.MCT-14-0354] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
76 Mohammadzadeh M, Faramarzi E, Mahdavi R, Nasirimotlagh B, Asghari Jafarabadi M. Effect of conjugated linoleic acid supplementation on inflammatory factors and matrix metalloproteinase enzymes in rectal cancer patients undergoing chemoradiotherapy. Integr Cancer Ther 2013;12:496-502. [PMID: 23632235 DOI: 10.1177/1534735413485417] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
77 Laszlo A, Thotala D, Hallahan DE. Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment. Cancer J 2013;19:238-46. [PMID: 23708071 DOI: 10.1097/PPO.0b013e31829a68eb] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
78 Guryanova OA, Bao S. How Scatter Factor Receptor c-MET Contributes to Tumor Radioresistance: Ready, Set, Scatter! JNCI: Journal of the National Cancer Institute 2011;103:617-9. [DOI: 10.1093/jnci/djr103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
79 Said RS, El-Demerdash E, Nada AS, Kamal MM. Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Biochem Pharmacol 2016;103:140-50. [PMID: 26827941 DOI: 10.1016/j.bcp.2016.01.019] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
80 Şengel-türk CT, Hasçiçek C, Dogan AL, Esendagli G, Guc D, Gönül N. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Drug Development and Industrial Pharmacy 2012;38:1107-16. [DOI: 10.3109/03639045.2011.641562] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
81 Tong D, Liu Q, Wang L, Xie Q, Pang J, Huang Y, Wang L, Liu G, Zhang D, Lan W, Jiang J. The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer Metastasis Rev 2018;37:355-68. [DOI: 10.1007/s10555-018-9752-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
82 Wu CT, Huang YC, Chen WC, Chen MF. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling. Front Oncol 2021;11:619365. [PMID: 34109109 DOI: 10.3389/fonc.2021.619365] [Reference Citation Analysis]
83 Kulkarni NN, Adase CA, Zhang LJ, Borkowski AW, Li F, Sanford JA, Coleman DJ, Aguilera C, Indra AK, Gallo RL. IL-1 Receptor-Knockout Mice Develop Epidermal Cysts and Show an Altered Innate Immune Response after Exposure to UVB Radiation. J Invest Dermatol 2017;137:2417-26. [PMID: 28754339 DOI: 10.1016/j.jid.2017.07.814] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
84 Astradsson T, Sellberg F, Berglund D, Ehrsson YT, Laurell GFE. Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study. Front Oncol 2019;9:1177. [PMID: 31750257 DOI: 10.3389/fonc.2019.01177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
85 Peng G, Cao RB, Li YH, Zou ZW, Huang J, Ding Q. Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells. Mol Med Rep 2014;10:1709-16. [PMID: 25109634 DOI: 10.3892/mmr.2014.2463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
86 Liang Y, Zheng J, Li X, Zheng W, Chen T. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells. European Journal of Medicinal Chemistry 2014;84:335-42. [DOI: 10.1016/j.ejmech.2014.07.032] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 5.1] [Reference Citation Analysis]
87 Choudhuri R, Degraff W, Gamson J, Mitchell JB, Cook JA. Guggulsterone-mediated enhancement of radiosensitivity in human tumor cell lines. Front Oncol 2011;1:19. [PMID: 22649756 DOI: 10.3389/fonc.2011.00019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]